echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Weekly Journal of the Pharmaceutical and Health Industry (July 6 - July 10)

    Weekly Journal of the Pharmaceutical and Health Industry (July 6 - July 10)

    • Last Update: 2020-07-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Joint release: Sina Pharmaceuticals, Sadie consultant policy direction this week a total of 4 policies and regulations issued, respectively, "the State Drug Administration on the dredging particles and other 17 drugs into over-the-counter drugs (No79 2020) " the State Drug Administration on the revision of Baoji oral liquid over-the-counter drug specification model "National Drug Drug" The Announcement of the Supervisory Board on the publication of three documents, namely ,No82 of 2020) and the Notice of the State Drug Administration on the Guidelines for the Preparation of The Manual of Hard Breathable Contact Mirrors for Corneal Plastics (Revised 2020), both issued by the State Drug Administration."Form 1 July 6 - July 10 issued the list of policies and regulations research and development new trends this week received a total of 175 drug registration declarations, divided by drug category, the largest number of chemical drug registration declarations received, 128 cases, accounting for 73%;classified by the type of registration declaration, 70 cases as supplementary applications, accounting for 40%; generic drug acceptance accounted for 10.29%; new drug acceptance accounted for 10.86 percent; importdrug acceptance accounted for 29.14 percent; import re-registration received 2.86 percentFigure 1 This week national acceptance of registered declaration of drug category figure 2 This week the national acceptance of drug registration declaration type consistency evaluation, this week a total of 7 application numbers were hosted, involving dexamethasone sodium phosphate injection, monite dispersal, cephalosporine tablets, injection with forsythtaminamine, injection of lansolazole, acetate aureat injection, injection of cephalosporine sodium spores and other 7 drug categories, allTable 2 July 6 - July 10 Consistency Evaluation Application Number List did not have consistency evaluation approval approved or approved this weekinvestment and financing to the domestic financing market, this week in the pharmaceutical health sector a total of five investment and financing incidents, of which only two incidents explicitly disclosed the amountinvestment targets are Nohui Health, Pharmaceutical Suwei, and Platinum Pharmaceuticals, Ruitong Bio and Asahi Medicalmainly involves genetic testing, new drug research and development, equipment research and development design and other fieldsTable 3 July 6 - July 10 mainland investment and financing events, Nohui Health Financing will be used to consolidate the expansion of the scale of its main cancer early sieve products, accelerate the development of new products, clinical research and market transformation, practice innovative diversified market strategy; D printers and personalized tongue-side invisible orthosis will increase production capacity, technology upgrades and market expansion, and platinum pharmaceutical financing will be used to accelerate the development of the company's innovative biopharmaceutical product pipeline for new coronaviruses in the field of tumor immunity, immune diseases, and huijian technology financing, based on advanced semiconductor nanochip technology and artificial intelligence algorithms, in the field of high-throughput clinical mass spectrometry and artificial intelligence olfactory accelerated industrialization layout, dedicated to the development of innovative diagnostic products clinical and clinical application scenarios, to solve the needfor innovative diagnostic products, Provides universal precision medicine and health monitoring solutionsin the foreign financing market, there were five investment and financing incidents in the medical and health sector this week, four of which were at the $10 million levelinvestmenttargets are Tranquis Therapeutics, kernel Inimmune, Orpyx Medical Technologies and ROKIT Healthcare, mainly in the areas of new drug research and development, life sciences intelligent hardwareTable 4 July 6 - July 10 overseas investment and financing events, Tranquis Therapeutics is a neurodegenerative diseases and aging-related diseases treatment of new drug developers, focusing on Parkinson's disease, Alzheimer's disease and other diseases of innovative drug research and development; Inimmune, a biopharmaceutical research and development company focused on bio-innovative drugs for tumors and bacterial diseases, Orpyx Medical Technologies, is a sensory insole sydd research and development manufacturer, and ROKIT Healthcare is a 4D bioprinting technology developer for therapeutic devices and implants.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.